D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 90 Citations 22,644 483 World Ranking 7793 National Ranking 4204

Research.com Recognitions

Awards & Achievements

2020 - Member of the National Academy of Medicine (NAM)

Member of the Association of American Physicians

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of study are Cancer research, Internal medicine, PI3K/AKT/mTOR pathway, Endocrinology and Protein kinase B. B. Mark Evers has researched Cancer research in several fields, including Carcinogenesis, Cancer stem cell, Downregulation and upregulation, Signal transduction and Metastasis. In his research, AKT2, P110α and Targeted Molecular Therapy is intimately related to Colorectal cancer, which falls under the overarching field of PI3K/AKT/mTOR pathway.

His work deals with themes such as Cholecystokinin, Receptor, Neurotensin and Curcumin, which intersect with Endocrinology. His work in Protein kinase B addresses subjects such as Intestinal mucosa, which are connected to disciplines such as Catenin, Wnt signaling pathway and Cell biology. His Cancer study combines topics from a wide range of disciplines, such as Oncology and Pathology.

His most cited work include:

  • Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion (582 citations)
  • Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer (442 citations)
  • mTORC1 and mTORC2 regulate EMT, motility and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways (386 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Cancer research, Internal medicine, Endocrinology, Cell biology and PI3K/AKT/mTOR pathway. The Cancer research study combines topics in areas such as Cancer cell, Cancer, Colorectal cancer, Protein kinase B and Cell growth. His work in Cell growth addresses issues such as Molecular biology, which are connected to fields such as Cellular differentiation, Transcription factor and Cell culture.

His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Gene expression and Oncology. His Receptor research extends to the thematically linked field of Endocrinology. His Cell biology study integrates concerns from other disciplines, such as Apoptosis and Intestinal mucosa.

He most often published in these fields:

  • Cancer research (44.60%)
  • Internal medicine (31.98%)
  • Endocrinology (22.61%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (44.60%)
  • Internal medicine (31.98%)
  • Colorectal cancer (14.66%)

In recent papers he was focusing on the following fields of study:

B. Mark Evers mainly investigates Cancer research, Internal medicine, Colorectal cancer, Neurotensin and Cancer. He combines subjects such as Wnt signaling pathway, Apoptosis, PI3K/AKT/mTOR pathway, Gene knockdown and AMPK with his study of Cancer research. He interconnects Cancer cell, Protein kinase B and Cell growth in the investigation of issues within PI3K/AKT/mTOR pathway.

His Internal medicine study combines topics in areas such as Endocrinology and Oncology. His work carried out in the field of Endocrinology brings together such families of science as Inflammation and Gut flora. His study explores the link between Colorectal cancer and topics such as Fatty acid synthase that cross with problems in Survivin.

Between 2017 and 2021, his most popular works were:

  • Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression (146 citations)
  • Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. (49 citations)
  • Colorectal cancer lung metastasis treatment with polymer-drug nanoparticles. (27 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

B. Mark Evers spends much of his time researching Cancer research, Cancer, Cell biology, Gene knockdown and Wnt signaling pathway. B. Mark Evers has included themes like PI3K/AKT/mTOR pathway, Apoptosis, Protein kinase B, Signal transduction and Chemotherapy in his Cancer research study. Cancer is a primary field of his research addressed under Internal medicine.

His Internal medicine study often links to related topics such as Gut flora. His Cell biology study combines topics in areas such as Glycolysis, Cell culture and Ligand. The Catenin research B. Mark Evers does as part of his general Wnt signaling pathway study is frequently linked to other disciplines of science, such as Mechanism, therefore creating a link between diverse domains of science.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Stabilization of Snail by NF-κB Is Required for Inflammation-Induced Cell Migration and Invasion

Yadi Wu;Jiong Deng;Piotr G. Rychahou;Suimin Qiu.
Cancer Cell (2009)

849 Citations

Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.

Chenfang Dong;Tingting Yuan;Yadi Wu;Yifan Wang.
Cancer Cell (2013)

693 Citations

mTORC1 and mTORC2 regulate EMT, motility and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways

Pat Gulhati;Kanika A. Bowen;Jianyu Liu;Payton D. Stevens.
Cancer Research (2011)

568 Citations

FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer.

Vijayanand Modur;Rakesh Nagarajan;B. Mark Evers;Jeffrey Milbrandt.
Journal of Biological Chemistry (2002)

466 Citations

G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer

Chenfang Dong;Yadi Wu;Jun Yao;Yifan Wang.
Journal of Clinical Investigation (2012)

451 Citations

Inflammation and the development of pancreatic cancer.

Buckminster Farrow;B.Mark Evers.
Surgical Oncology-oxford (2002)

442 Citations

Disrupting the Interaction of BRD4 With Diacetylated Twist Suppresses Tumorigenesis in Basal-Like Breast Cancer

Jian Shi;Yifan Wang;Yifan Wang;Lei Zeng;Yadi Wu.
Cancer Cell (2014)

412 Citations

The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1

Yiwei Lin;Yadi Wu;Junlin Li;Chenfang Dong.
The EMBO Journal (2010)

352 Citations

mTOR inhibitors in cancer therapy

Yekaterina Y. Zaytseva;Joseph D. Valentino;Prateek gulhati;B. Mark Evers.
Cancer Letters (2012)

318 Citations

Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway

Shawn D. Larson;Lindsey N. Jackson;Taylor S. Riall;Tatsuo Uchida.
Journal of The American College of Surgeons (2007)

292 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing B. Mark Evers

Peixuan Guo

Peixuan Guo

The Ohio State University

Publications: 85

Robert T. Jensen

Robert T. Jensen

National Institutes of Health

Publications: 29

Enrique Rozengurt

Enrique Rozengurt

University of California, Los Angeles

Publications: 21

Irvin M. Modlin

Irvin M. Modlin

Yale University

Publications: 20

Vincent W. Yang

Vincent W. Yang

Stony Brook University

Publications: 17

Charalabos Pothoulakis

Charalabos Pothoulakis

University of California, Los Angeles

Publications: 16

Daniel J. Drucker

Daniel J. Drucker

Lunenfeld-Tanenbaum Research Institute

Publications: 16

Herbert Chen

Herbert Chen

University of Alabama at Birmingham

Publications: 15

Zhao Zhong Chong

Zhao Zhong Chong

University of Illinois at Chicago

Publications: 15

Stephen J. Pandol

Stephen J. Pandol

Cedars-Sinai Medical Center

Publications: 15

Marc D. Basson

Marc D. Basson

University of North Dakota

Publications: 15

David N. Herndon

David N. Herndon

The University of Texas Medical Branch at Galveston

Publications: 15

Mark P. Mattson

Mark P. Mattson

Johns Hopkins University School of Medicine

Publications: 14

Simone Fulda

Simone Fulda

Goethe University Frankfurt

Publications: 14

Ashok K. Saluja

Ashok K. Saluja

University of Miami

Publications: 14

Theoharis C. Theoharides

Theoharis C. Theoharides

Nova Southeastern University

Publications: 14

Trending Scientists

John B. Carter

John B. Carter

IBM (United States)

Benjamin C. M. Fung

Benjamin C. M. Fung

McGill University

John G. Harris

John G. Harris

University of Florida

Holger R. Roth

Holger R. Roth

Nvidia (United States)

Laurent Bazinet

Laurent Bazinet

Université Laval

Makoto Kasu

Makoto Kasu

Saga University

Sang Geon Kim

Sang Geon Kim

Seoul National University

Chusi Li

Chusi Li

Indiana University

Alfredo Pérez-González

Alfredo Pérez-González

Complutense University of Madrid

Stephen E. Laubach

Stephen E. Laubach

The University of Texas at Austin

Andreas Massling

Andreas Massling

Aarhus University

Catie Chang

Catie Chang

Vanderbilt University

Hiroki Yoshida

Hiroki Yoshida

Saga University

Kenneth E. Ugen

Kenneth E. Ugen

University of South Florida

Nadine E. Foster

Nadine E. Foster

University of Queensland

Silvano Desidera

Silvano Desidera

National Institute for Astrophysics

Something went wrong. Please try again later.